Bill

Bill > HB2060


TN HB2060

TN HB2060
AN ACT to amend Tennessee Code Annotated, Title 33 and Title 53, relative to the treatment of opiate addiction.


summary

Introduced
01/24/2024
In Committee
03/27/2024
Crossed Over
Passed
05/09/2024
Dead
Signed/Enacted/Adopted
05/09/2024

Introduced Session

113th General Assembly

Bill Summary

As enacted, makes changes to the law relative to prescribing buprenorphine products. - Amends TCA Title 33 and Title 53.

AI Summary

This bill amends Tennessee's laws related to the treatment of opioid addiction. It makes changes to the definition of "nonresidential office-based opiate treatment facility" to exclude certain types of healthcare facilities. It also modifies requirements for healthcare providers who prescribe buprenorphine, a medication used to treat opioid use disorder, including allowing them to prescribe a mono product or buprenorphine without naloxone in certain cases. Additionally, the bill increases the maximum number of patients a provider can treat with buprenorphine from 50 to 100. These changes are intended to facilitate access to and improve the treatment of opioid addiction in Tennessee.

Committee Categories

Health and Social Services

Sponsors (6)

Last Action

Comp. became Pub. Ch. 808 (on 05/09/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...